Trial Readiness of Cavernous Malformations With Symptomatic Hemorrhage, Part II: Biomarkers and Trial Modeling. Hage S, Kinkade S, Girard R, Flemming KD, et al. Stroke 2024;55:31-39.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Hage S, Kinkade S, Girard R, Flemming KD, et al. Trial Readiness of Cavernous Malformations With Symptomatic Hemorrhage, Part II: Biomarkers and Trial Modeling. Stroke 2024;55:31-39.
PMID: 38134265